Breaking News

Aegerion Appoints U.S. President

To lead anticipated commercial launch of Lomitapide

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Aegerion Pharmaceuticals, Inc. has appointed Craig E. Fraser as president, U.S. Mr. Fraser was most recently vice president, Global Disease Areas at Pfizer, responsible for the commercial development and global marketing for the specialty cardiovascular, anti-bacterial, anti-fungal, gastrointestinal and anti-viral disease areas. Prior to Pfizer, Mr. Fraser was vice president and global business manager at Wyeth, where he led the institutional/infectious disease business. Mr. Fraser also held sev...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters